Search Results
You are looking at 1 - 1 of 1 items for
- Author: Claude Remacle x
- Refine by access: All content x
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Patrice D Cani in
Google Scholar
PubMed
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Catherine A Daubioul in
Google Scholar
PubMed
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Brigitte Reusens in
Google Scholar
PubMed
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Claude Remacle in
Google Scholar
PubMed
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Grégory Catillon in
Google Scholar
PubMed
Unit of Animal Biology, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Nathalie M Delzenne in
Google Scholar
PubMed
We have evaluated the influence of oligofructose (OFS), a fermentable dietary fibre, on glucose homeostasis, insulin production and intestinal glucagon-like peptide-1 (GLP-1) in streptozotocin-treated diabetic rats.
Male Wistar rats received either i.v. streptozotocin (STZ; 40 mg/kg) or vehicle (CT); one week later, they were fed for 6 weeks with either the standard diet (STZ-CT), or with a diet containing 10% oligofructose (STZ-OFS); both diets were available ad libitum. In a second set of experiments (duration 4 weeks), a supplemental group of food-restricted rats (STZ-Res) receiving a similar intake as CT rats, was added.
OFS improved glucose tolerance and reduced food intake as compared with STZ-CT rats in both the post-prandial state and after an oral glucose tolerance test. After 6 weeks, portal and pancreatic insulin concentrations were doubled in STZ-OFS rats. Food restriction improved these parameters when compared with STZ-CT rats, but to a lesser extent than in the STZ-OFS group. We have shown that OFS treatment increased portal and colonic GLP-1(7–36) amide levels and doubled colonic proglucagon and prohormone convertase 1 mRNA levels; both OFS and food restriction lowered ileal GLP-1(7–36) amide levels as compared with levels in STZ-CT rats.
We propose that OFS, through its fermentation in the colon, promotes the expression and secretion of colonic peptides, namely GLP-1(7–36) amide, with beneficial consequences on glycaemia, insulin secretion and hyperphagia in diabetic rats.
